NEXT Financial Group, Inc - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$153,000
+1.3%
1,695
+4.1%
0.01%
-16.7%
Q3 2021$151,000
+2.7%
1,629
-14.1%
0.01%0.0%
Q2 2021$147,000
+14.8%
1,896
+10.4%
0.01%
+9.1%
Q1 2021$128,000
+12700.0%
1,717
+42825.0%
0.01%
Q3 2020$1,000
-92.9%
4
-96.9%
0.00%
-100.0%
Q4 2018$14,000
-70.8%
131
-56.3%
0.00%
-86.4%
Q3 2018$48,000
-99.9%
300
-75.0%
0.02%
+120.0%
Q2 2017$40,000,000
+48.1%
1,200
+20.0%
0.01%
+100.0%
Q4 2016$27,000,000
+44162.3%
1,0000.0%0.01%
-54.5%
Q3 2016$61,000
+221.1%
1,0000.0%0.01%
+83.3%
Q2 2016$19,000
+533.3%
1,000
+900.0%
0.01%
+500.0%
Q4 2015$3,0001000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders